Trials / Completed
CompletedNCT05998200
Safety of Serum for Post-Inflammatory on Hyperpigmentation Skin
Safety of Serum Containing Alpha Hydroxy Acid (AHA) and Polyglutamate Acid Derivatives for Post-Inflammatory on Hyperpigmentation Skin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- USMARI Research & Innovation Centre · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This study aims to investigate the safety of serum product containing low dose of alpha hydroxy acid (AHA) i.e. 1% Glycolic acid and Lactic acid and Polyglutamate acid derivatives (PGA) for post-inflammatory hyperpigmentation skin in Malaysia. The study duration is 8 weeks and the skin assessment will be carried out at baseline, week 4 and week 8.The main questions this study aims to answer are: 1. To investigate the safety of serum containing low concentration AHA (1% Glycolic acid and Lactic acid) and PGA for post-inflammatory hyperpigmentation skin among Malaysian. 2. To assess the patient satisfaction after using serum containing low concentration AHA (1% Glycolic acid and Lactic acid) and PGA among Malaysian.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Serum with low concentration AHA (1% Glycolic acid and Lactic acid) and PGA | Participants will used the serum twice daily for 8 weeks |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2025-10-30
- Completion
- 2025-10-30
- First posted
- 2023-08-18
- Last updated
- 2026-03-06
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT05998200. Inclusion in this directory is not an endorsement.